Hydroquinone USP
Finished product specification did not meet USP specifications.
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Subpotency: one product for active ingredient assay and another one for preservative assay
Cause type: Wrong potency / content
Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.
Hydroquinone, USP, 4% Skin Bleaching Cream, packaged in 1 oz (28.35g) tube, Rx only, Manufactured for: Westminster Pharmaceuticals, LLC Nashville, TN 37217, NDC 69367-174-01 UPC 3 69367 17401 5
Compare with the code on your package — it is the most precise check available.
Drug: Hydroquinone
From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.
| Product | Strength | Form & route | Labeler | Type |
|---|---|---|---|---|
| Hydroquinone NDC 69367-0174 |
40 mg/g | Cream Topical |
Westminster Pharmaceuticals, LLC | Rx |
Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
Finished product specification did not meet USP specifications.
GMP Deviations
Lack of Processing Control
CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.
Failed Stability Specifications: Out-of-specification for viscosity, pH and specific gravity
Does Not Meet USP or OTC Monograph: Product exceeds USP specification for alcohol content
Finished product specification did not meet USP specifications.
Subpotency: one product for active ingredient assay and another one for preservative assay
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.